Preview Mode Links will not work in preview mode

PODCAST SBD - PROFISSIONAL

  1. All Episodes
  2. Segurança CV da Dulaglutida - estudo REWIND - Roberto Betti - #Podcast 169

Segurança CV da Dulaglutida - estudo REWIND - Roberto Betti - #Podcast 169

Mar 24, 2021

Autor: Roberto Betti

Ref: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.